News + Research
I wanted to share a quick update with you on some research I’m doing, investigating medical cannabis use & effectiveness in older adults.
Its excellent safety profile and multimodality make medical cannabis particularly appropriate and beneficial in the senior population -- especially as polypharmacy is the number one cause of hospitalizations due to adverse drug reactions amongst this group.
Have a watch of this short video for more info.
For the full article referenced click here.
There have been several studies published that have shown a correlation between increased access to legal medical cannabis and a reduction in opioid usage and related harms; however, most of them have focused on the U.S.
In one of the largest polling studies to date, investigators looked at over 2032 surveys provided by Canadian Licensed Producers to understand the patterns of medical cannabis use and its substitution for pharmaceutical and illicit drugs.
Published in the Harm Reduction Journal, the study found the most commonly documented substitution was for prescription drugs (69% of participants), followed by alcohol (44.5%)
This study adds another uniquely Canadian perspective to the growing body of evidence that “increased regulated access to medical and recreational cannabis can result in a reduction in the use of and subsequent harms associated with opioids, alcohol, tobacco and other substances.”
Full article available here.
